We are live on
!
Find out more
KKRC
Kohlberg Kravis Roberts & Co Portfolio holdings
AUM
$5.35B
1-Year Est. Return
63.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
+63.01%
3 Year Est. Return
+297.95%
5 Year Est. Return
+219.08%
10 Year Est. Return
+856.54%
AUM
$3.33B
AUM Growth
-$544M
(-14%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-31.97%
Top 10 Holdings %
Top 10 Hldgs %
89.16%
Holding
71
New
1
Increased
–
Reduced
4
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BrightView Holdings
BV
|
+$223M |
| 2 |
TGAN
Transphorm, Inc. Common Stock
TGAN
|
+$120M |
| 3 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$116M |
| 4 |
FS KKR Capital
FSK
|
+$73.9M |
| 5 |
Viasat
VSAT
|
+$8.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.57% |
| 2 | Industrials | 13.22% |
| 3 | Technology | 6.47% |
| 4 | Real Estate | 2.71% |
| 5 | Communication Services | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
BrightSpring Health Services
BTSG
$14.2B
| $924M | 27.72% |
81,339,986
| – | – |
|
2
BridgeBio Pharma
BBIO
$16.8B
| $787M | 23.6% |
31,060,971
| – | – |
|
|
3
BrightView Holdings
BV
$1.3B
| $441M | 13.22% |
33,133,123
-17,500,000
| -35% | -$223M |
|
|
PGRU
4
DELISTED
PropertyGuru Group Limited
PGRU
| $211M | 6.33% |
43,475,124
| – | – |
|
|
KREF
5
KKR Real Estate Finance Trust
KREF
$471M
| $90.5M | 2.71% |
10,000,001
| – | – |
|
6
Madison Square Garden
MSGS
$9.58B
| $57.4M | 1.72% |
305,068
| – | – |
|
7
DoorDash
DASH
$85.2B
| $46.7M | 1.4% |
429,383
| – | – |
|
8
Bausch Health
BHC
$1.69B
| $36.5M | 1.09% |
5,235,000
| – | – |
|
|
9
FS KKR Capital
FSK
$3.08B
| $19.3M | 0.58% |
980,587
-3,759,459
| -79% | -$73.9M |
|
|
10
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
| $16.1M | 0.48% |
+150,200
| New | +$16M |
|
11
Applovin
APP
$140B
| $11.4M | 0.34% |
136,794
-29,773
| -18% | -$2.31M |
|
12
Crescent Energy
CRGY
$3.44B
| $6.78M | 0.2% |
572,354
| – | – |
|
13
Coherus Oncology
CHRS
$222M
| $5.25M | 0.16% |
3,036,076
| – | – |
|
|
14
Viasat
VSAT
$10.2B
| $4.91M | 0.15% |
386,516
-536,030
| -58% | -$8.55M |
|
|
EDR
15
DELISTED
Endeavor Group Holdings, Inc.
EDR
| – | – |
-4,495,920
| Closed | -$116M |
|
|
TGAN
16
DELISTED
Transphorm, Inc. Common Stock
TGAN
| – | – |
-24,411,968
| Closed | -$120M |
|
Similar funds
DPL
LP
ENV
CBUSF
WL
DRZID
FMWA
SDIC
Kohlberg Kravis Roberts & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Kohlberg Kravis Roberts & Co held 71 positions worth $3.33B, down 14% from $3.88B the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Kohlberg Kravis Roberts & Co withdrew a net $1.07B in Q2 2024, closing 2 positions and reducing 4 holdings. Its most notable exit was Transphorm, Inc. Common Stock, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 49% a quarter earlier, followed by Industrials and Technology.
Against the trend, Kohlberg Kravis Roberts & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $16.1M.
- Kohlberg Kravis Roberts & Co's largest Q2 2024 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 150,200 shares worth $16.1M.
- Kohlberg Kravis Roberts & Co's biggest Q2 2024 reduction was BrightView Holdings, cutting an estimated $223M.
- Kohlberg Kravis Roberts & Co fully exited Transphorm, Inc. Common Stock in Q2 2024, selling an estimated $120M.
- Kohlberg Kravis Roberts & Co's ten largest holdings make up 89% of its $3.33B portfolio in Q2 2024.
- Kohlberg Kravis Roberts & Co opened 1 new position and closed 2 in Q2 2024.
- Kohlberg Kravis Roberts & Co's portfolio value fell 14% quarter-over-quarter to $3.33B.
Based on Kohlberg Kravis Roberts & Co's 13F filing for Q2 2024, filed 14 Aug 2024.